Free tool
FAERS Monitor: Cardizem
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018602 or its brand name (Cardizem, Diltiazem Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
23,272
Serious
17,790
76% of reports
Hospitalization
10,297
Death reported
4,039
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea2,392
- fatigue2,001
- pain1,858
- nausea1,717
- dizziness1,638
- diarrhoea1,549
- fall1,526
- headache1,486
- drug ineffective1,458
- arthralgia1,291
- atrial fibrillation1,262
- asthenia1,237
- hypotension1,224
- pneumonia1,165
- pruritus1,122
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 837 |
| 2005 | 894 |
| 2006 | 759 |
| 2007 | 579 |
| 2008 | 568 |
| 2009 | 649 |
| 2010 | 920 |
| 2011 | 966 |
| 2012 | 981 |
| 2013 | 865 |
| 2014 | 988 |
| 2015 | 1,179 |
| 2016 | 1,196 |
| 2017 | 1,073 |
| 2018 | 960 |
| 2019 | 894 |
| 2020 | 956 |
| 2021 | 1,146 |
| 2022 | 1,687 |
| 2023 | 1,288 |
| 2024 | 1,524 |
| 2025 | 1,457 |
| 2026 | 905 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,887 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| atrial fibrillationSignal | 1,262 | 11.9 | 11.2 | 12,424 |
| hypotensionSignal | 1,224 | 5.5 | 5.2 | 4,568 |
| fallSignal | 1,526 | 4.2 | 4.0 | 3,699 |
| dyspnoeaSignal | 2,392 | 3.8 | 3.7 | 5,118 |
| pneumoniaSignal | 1,165 | 3.3 | 3.1 | 1,845 |
| astheniaSignal | 1,237 | 3.0 | 2.8 | 1,649 |
| dizzinessSignal | 1,638 | 3.0 | 2.8 | 2,190 |
| arthralgiaSignal | 1,291 | 2.8 | 2.7 | 1,531 |
| painSignal | 1,858 | 2.7 | 2.6 | 2,105 |
| pruritusSignal | 1,122 | 2.6 | 2.5 | 1,163 |
| fatigueSignal | 2,001 | 2.3 | 2.2 | 1,566 |
| diarrhoeaSignal | 1,549 | 2.2 | 2.1 | 1,006 |
| headacheSignal | 1,486 | 2.1 | 2.0 | 933 |
| nausea | 1,717 | 2.0 | 1.9 | 840 |
| drug ineffective | 1,458 | 1.0 | 1.0 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.